Brainify.AI logo

Brainify.AI

New York, NY

Brainify.AI is a decision support tool for depression screening and treatment decisions. Brainify is examining EEG-biomarkers to diagnose depression, determine the stage and type of the disorder, and predict treatment response. No two brains are identical; therefore, Brainify changes a paradigm from “one-size-fits-all” psychiatry to more personalized treatment to enable patients to receive the best Rx medication. Our product relies on two decades of scientific research in psychiatry, neuroscience, and psychopharmacology

brainify.ai

Company Details

Founded

2021

Employees

Between 10 - 50 employees

Raised

$1,600,000

Headquarters Location

New York, NY

Public

No

Acquired

No

CEO

Mariam Khayretdinova

Founders

Ivan Mishanin
Ivan Mishanin
Mariam Khayretdinova
Mariam Khayretdinova

Company Collections

These are collections Brainify.AI is a part of. Click on the collection name to view similar companies.